SCHEMBL4683751

SCHEMBL4683751

CC/C=C/CCCC(CC)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ ALDH1A1 P00352 6/20 0.47
▸ CYP19A1 P11511 4/20 0.47
▸ F7 P08709 3/20 0.47
▸ F3 P13726 3/20 0.47
▸ PPARG P37231 3/20 0.47
▸ OXER1 Q8TDS5 3/20 0.47
▸ PTGS1 P23219 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ PPARD Q03181 2/20 0.47
▸ PPARA Q07869 2/20 0.47
▸ RXRA P19793 2/20 0.47
▸ ADORA3 P0DMS8 2/20 0.47
▸ MAPT P10636 4/20 0.44
▸ FFAR1 O14842 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ NR1I2 O75469 2/20 0.44
▸ PTGS2 P35354 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1027173 1.00 CA2 (0.59) CA2MAPK1ALDH1A1CYP19A1F7
Hydrochloric Acid SCHEMBL28412481 0.98 CA2 (0.57) CA2MAPK1ALDH1A1CYP19A1F7
SCHEMBL28388465 0.95 ALDH1A1 (0.56) CA2MAPK1ALDH1A1CYP19A1F7
SCHEMBL4585139 0.94 CA2 (0.57) CA2MAPK1ALDH1A1CYP19A1F7
SCHEMBL4585143 0.94 CA2 (0.57) CA2MAPK1ALDH1A1CYP19A1F7
SCHEMBL28945181 0.93 CA2 (0.55) CA2MAPK1ALDH1A1CYP19A1F7
SCHEMBL19856371 0.93 CA2 (0.55) CA2MAPK1ALDH1A1CYP19A1F7
SCHEMBL3216717 0.90 ALDH1A1 (0.56) CA2MAPK1ALDH1A1CYP19A1F7
SCHEMBL15636724 0.89 CA2 (0.64) CA2MAPK1F7F3MAPT
SCHEMBL15636725 0.89 CA2 (0.64) CA2MAPK1F7F3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448923-A Pyrimido-cyclic compounds, process for their preparation and their use 青煜医药研发(上海)有限公司 2022-12-09 — — CN disclosed
CN-110156786-B Pyrimido-cyclic compounds, process for their preparation and their use 青煜医药研发(上海)有限公司 2022-06-03 — — CN disclosed
EP-2877471-A1 SPIRO - FUSED PIPERIDINE DERIVATIVES FOR USE AS INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL Merck Sharp & Dohme Corp. (US) 2015-06-03 — — EP disclosed
WO-2014018764-A1 SPIRO - FUSED PIPERIDINE DERIVATIVES FOR USE AS INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2014-01-30 — — WO disclosed
EP-1910364-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2008-04-16 — — EP disclosed
WO-2007011833-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2007-01-25 — — WO disclosed
Send feedback